Hematology TimesStudy: Reference pricing does reduce prescription costsAugust 23, 2017PharmacyRelated Issues
Hematology TimesTriplet eradicates B-ALL, prolongs survival in miceAugust 23, 2017Leukemia, Myelodysplasia, TransplantationALL
Hematology TimesDrug granted orphan designation for chemo-induced ototoxicityAugust 23, 2017Lymphoma & Plasma Cell DisordersPediatricsPharmacyNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesAntibody could treat AML, MM, and NHLAugust 22, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaAMLNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesFDA grants drug orphan designation for AMLAugust 22, 2017Leukemia, Myelodysplasia, TransplantationPharmacyAML
Hematology NewsPVC phlebitis rates varied widely, depending on assessment toolAugust 21, 2017ThrombosisTransfusion Medicine
Hematology NewsL-glutamine to prevent sickle cell complications featured in FDA podcastAugust 21, 2017ThrombosisAnemia
Hematology NewsInotuzumab ozogamicin tied to sinusoidal obstruction syndrome in ALLAugust 21, 2017ThrombosisALLLeukemia, Myelodysplasia, Transplantation
Hematology TimesVitamin C could help treat TET2-mutant leukemiasAugust 21, 2017Leukemia, Myelodysplasia, Transplantation
The Journal of Community and Supportive OncologyRibociclib: another CDK inhibitor hits the mark in breast cancerAugust 20, 2017Breast Cancer
The Journal of Community and Supportive OncologyApproval makes olaratumab the first first-line treatment option for soft tissue sarcoma in more than 40 yearsAugust 20, 2017Sarcoma & GIST
Oncology PracticeExelixis seeks expanded indication for cabozantinib in RCCAugust 18, 2017Renal Cell Carcinoma
